(Q79297587)
Statements
A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer (English)
Alex A Adjei
Charles Erlichman
Stephanie L Safgren
Matthew M Ames
Grzegorz S Nowakowski
Andrea K McCollum
Sumithra J Mandrekar